Genomind's Series A - III Round

Genomind raised a round of funding on February 08, 2016. Investors include Claritas Capital.

Genomind is a personalized medicine company committed to the discovery of the underlying causes of neuropsychiatric disorders and supporting the development of personalized medicine that improves pati…

Articles about Genomind's Series A - III Round: